SABATINI BRENT (SVP, Chief Accounting Officer) sold 3.1% of their position (1.53K shares) of VIR BIOTECHNOLOGY, INC. on the open market
Open‑market sale worth $11.9K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/18/2026ACC: 0001628280-26-008984
Officer· SVP, Chief Accounting Officer
Since Feb 2026
-1.53K
Net shares
Net seller
$11.9K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
1.53K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−1.53K
Price / share
$7.79
Trade value
$11.92K
% of position
3.1%
2/13/2026
49.40K→47.87K
Total
Net shares
−1.53K
Net value
-$11.92K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/13/2026 | S · Sale | −1.53K | $7.79 | $11.92K | 3.1% | 49.40K | 47.87K |
| Total | −1.53K | -$11.92K | ||||||
Derivative Transactions0
No derivative transactions reported